Bone regeneration from mesenchymal stem cells (MSCs) and compact bone-derived MSCs as an animal model

Japanese Dental Science Review

Volumn 49, Issue 1, 2013, Pages 35-44

  Yamachika, Eiki ^a   Iida, Seiji ^b  

^a OKAYAMA UNIVERSITY HOSPITAL   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Bone regeneration; Mesenchymal stem cells

Indexed keywords

EID: 84874260541     PISSN: 18827616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdsr.2012.11.003     Document Type: Review

References (98)

1. Friedenstein A.J., Petrakova K.V., Kurolesova A.I., Frolova G.P. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 1968, 6:230-247.
2. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
3. Horwitz E.M., Le Blanc K., Dominici M., Mueller I., Slaper-Cortenbach I., Marini F.C., et al. Clarification of the nomenclature for MSC: the international society for cellular therapy position statement. Cytotherapy 2005, 7:393-395.
4. Bernardo M.E., Locatelli F., Fibbe W.E. Mesenchymal stromal cells. Ann N Y Acad Sci 2009, 1176:101-117.
5. Qian L., Huang Y., Spencer C.I., Foley A., Vedantham V., Liu L., et al. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 2012, 485:593-598.
6. Pang Z.P., Yang N., Vierbuchen T., Ostermeier A., Fuentes D.R., Yang T.Q., et al. Induction of human neuronal cells by defined transcription factors. Nature 2011, 476:220-223.
7. Friedenstein A.J., Chailakhyan R.K., Gerasimov U.V. Bone-marrow osteogenic stem-cells - invitro cultivation and transplantation in diffusion-chambers. Cell Tissue Kinet 1987, 20:263-272.
8. Anjos-Afonso F., Siapati E.K., Bonnet D. In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions. J Cell Sci 2004, 117:5655-5664.
9. Nauta A.J., Fibbe W.E. Immunomodulatory properties of mesenchymal stromal cells. Blood 2007, 110:3499-3506.
10. Locatelli F., Maccario R., Frassoni F. Mesenchymal stromal cells, from indifferent spectators to principal actors. Are we going to witness a revolution in the scenario of allograft and immune-mediated disorders?. Haematologica 2007, 92:872-877.
11. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F.C., Krause D.S., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317.
12. Wongchuensoontorn C., Liebehenschel N., Schwarz U., Schmelzeisen R., Gutwald R., Ellis E., et al. Application of a new chair-side method for the harvest of mesenchymal stem cells in a patient with nonunion of a fracture of the atrophic mandible - a case report. J Cranio Maxill Surg 2009, 37:155-161.
13. Gronthos S., Franklin D.M., Leddy H.A., Robey P.G., Storms R.W., Gimble J.M. Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol 2001, 189:54-63.
14. Tsai M.S., Lee J.L., Chang Y.J., Hwang S.M. Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod 2004, 19:1450-1456.
15. Igura K., Zhang X., Takahashi K., Mitsuru A., Yamaguchi S., Takashi T.A. Isolation and characterization of mesenchymal progenitor cells from chorionic villi of human placenta. Cytotherapy 2004, 6:543-553.
16. Zuk P.A., Zhu M., Ashjian P., De Ugarte D.A., Huang J.I., Mizuno H., et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002, 13:4279-4295.
17. Hasebe Y., Hasegawa S., Hashimoto N., Toyoda M., Matsumoto K., Umezawa A., et al. Analysis of cell characterization using cell surface markers in the dermis. J Dermatol Sci 2011, 62:98-106.
18. Yu G., Wu X., Dietrich M.A., Polk P., Scott L.K., Ptitsyn A.A., et al. Yield and characterization of subcutaneous human adipose-derived stem cells by flow cytometric and adipogenic mRNA analyzes. Cytotherapy 2010, 12:538-546.
19. Kyurkchiev S., Shterev A., Dimitrov R. Assessment of presence and characteristics of multipotent stromal cells in human endometrium and decidua. Reprod Biomed Online 2010, 20:305-313.
20. Royer-Pokora B., Busch M., Beier M., Duhme C., de Torres C., Mora J., et al. Wilms tumor cells with WT1 mutations have characteristic features of mesenchymal stem cells and express molecular markers of paraxial mesoderm. Hum Mol Genet 2010, 19:1651-1668.
21. Orciani M., Mariggio M.A., Morabito C., Di Benedetto G., Di Primio R. Functional characterization of calcium-signaling pathways of human skin-derived mesenchymal stem cells. Skin Pharmacol Physiol 2010, 23:124-132.
22. Ohgushi H., Kotobuki N., Funaoka H., Machida H., Hirose M., Tanaka Y., et al. Tissue engineered ceramic artificial joint - ex vivo osteogenic differentiation of patient mesenchymal cells on total ankle joints for treatment of osteoarthritis. Biomaterials 2005, 26:4654-4661.
23. Iwata T., Yamato M., Zhang Z., Mukobata S., Washio K., Ando T., et al. Validation of human periodontal ligament-derived cells as a reliable source for cytotherapeutic use. J Clin Periodontol 2010, 37:1088-1099.
24. Latif N., Sarathchandra P., Thomas P.S., Antoniw J., Batten P., Chester A.H., et al. Characterization of structural and signaling molecules by human valve interstitial cells and comparison to human mesenchymal stem cells. J Heart Valve Dis 2007, 16:56-66.
25. Buhring H.J., Treml S., Cerabona F., de Zwart P., Kanz L., Sobiesiak M. Phenotypic characterization of distinct human bone marrow-derived MSC subsets. Ann N Y Acad Sci 2009, 1176:124-134.
26. Zvaifler N.J., Marinova-Mutafchieva L., Adams G., Edwards C.J., Moss J., Burger J.A., et al. Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res 2000, 2:477-488.
27. Simmons P.J., Torok-Storb B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 1991, 78:55-62.
28. Simmons P.J., Gronthos S., Zannettino A., Ohta S., Graves S. Isolation, characterization and functional activity of human marrow stromal progenitors in hemopoiesis. Prog Clin Biol Res 1994, 389:271-280.
29. Miura M., Gronthos S., Zhao M., Lu B., Fisher L.W., Robey P.G., et al. SHED: stem cells from human exfoliated deciduous teeth. Proc Natl Acad Sci U S A 2003, 100:5807-5812.
30. Conget P.A., Minguell J.J. Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol 1999, 181:67-73.
31. Parte S., Bhartiya D., Telang J., Daithankar V., Salvi V., Zaveri K., et al. Detection, characterization, and spontaneous differentiation in vitro of very small embryonic-like putative stem cells in adult mammalian ovary. Stem Cells Dev 2011, 20:1451-1464.
32. De Bari C., Dell'Accio F., Tylzanowski P., Luyten F.P. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 2001, 44:1928-1942.
33. Fukumoto T., Sperling J.W., Sanyal A., Fitzsimmons J.S., Reinholz G.G., Conover C.A., et al. Combined effects of insulin-like growth factor-1 and transforming growth factor-beta 1 on periosteal mesenchymal cells during chondrogenesis in vitro. Osteoarthritis Cartilage 2003, 11:55-64.
34. Cao B.H., Zheng B., Jankowski R.J., Kimura S., Ikezawa M., Deasy B., et al. Muscle stem cells differentiate into haematopoietic lineages but retain myogenic potential. Nat Cell Biol 2003, 5:640-646.
35. Prockop D.J. Marrow stromal cells as stem cells for continual renewal of nonhematopoietic tissues and as potential vectors for gene therapy. J Cell Biochem 1998, 284-285.
36. De Ugarte D.A., Morizono K., Elbarbary A., Alfonso Z., Zuk P.A., Zhu M., et al. Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 2003, 174:101-109.
37. Sekiya I., Larson B.L., Smith J.R., Pochampally R., Cui J.G., Prockop D.J. Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 2002, 20:530-541.
38. Prockop D.J., Gregory C.A., Spees J.L. One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues. Proc Natl Acad Sci U S A 2003, 100:11917-11923.
39. Colter D.C., Sekiya I., Prockop D.J. Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci U S A 2001, 98:7841-7845.
40. Bochev I., Elmadjian G., Kyurkchiev D., Tzvetanov L., Altankova I., Tivchev P., et al. Mesenchymal stem cells from human bone marrow or adipose tissue differently modulate mitogen-stimulated B-cell immunoglobulin production in vitro. Cell Biol Int 2008, 32:384-393.
41. Davani B., Ikonomou L., Raaka B.M., Geras-Raaka E., Morton R.A., Marcus-Samuels B., et al. Human islet-derived precursor cells are mesenchymal stromal cells that differentiate and mature to hormone-expressing cells in vivo. Stem Cells 2007, 25:3215-3222.
42. Kern S., Eichler H., Stoeve J., Kluter H., Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006, 24:1294-1301.
43. Wagner W., Wein F., Seckinger A., Frankhauser M., Wirkner U., Krause U., et al. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 2005, 33:1402-1416.
44. Lee K., Chan C.K., Patil N., Goodman S.B. Cell therapy for bone regeneration - bench to bedside. J Biomed Mater Res B Appl Biomater 2009, 89:252-263.
45. Slater B.J., Kwan M.D., Gupta D.M., Panetta N.J., Longaker M.T. Mesenchymal cells for skeletal tissue engineering. Expert Opin Biol Ther 2008, 8:885-893.
46. El Tamer M.K., Reis R.L. Progenitor and stem cells for bone and cartilage regeneration. J Tissue Eng Regen Med 2009, 3:327-337.
47. Chevallier N., Anagnostou F., Zilber S., Bodivit G., Maurin S., Barrault A., et al. Osteoblastic differentiation of human mesenchymal stem cells with platelet lysate. Biomaterials 2010, 31:270-278.
48. Zhang Z.Y., Teoh S.H., Chong M.S., Lee E.S., Tan L.G., Mattar C.N., et al. Neo-vascularization and bone formation mediated by fetal mesenchymal stem cell tissue-engineered bone grafts in critical-size femoral defects. Biomaterials 2010, 31:608-620.
49. Lin Y., Tang W., Wu L., Jing W., Li X., Wu Y., et al. Bone regeneration by BMP-2 enhanced adipose stem cells loading on alginate gel. Histochem Cell Biol 2008, 129:203-210.
50. Yoon E., Dhar S., Chun D.E., Gharibjanian N.A., Evans G.R. In vivo osteogenic potential of human adipose-derived stem cells/poly lactide-co-glycolic acid constructs for bone regeneration in a rat critical-sized calvarial defect model. Tissue Eng 2007, 13:619-627.
51. Bohnenblust M.E., Steigelman M.B., Wang Q., Walker J.A., Wang H.T. An experimental design to study adipocyte stem cells for reconstruction of calvarial defects. J Craniofac Surg 2009, 20:340-346.
52. Li H., Dai K., Tang T., Zhang X., Yan M., Lou J. Bone regeneration by implantation of adipose-derived stromal cells expressing BMP-2. Biochem Biophys Res Commun 2007, 356:836-842.
53. Phinney D.G., Kopen G., Isaacson R.L., Prockop D.J. Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: variations in yield, growth, and differentiation. J Cell Biochem 1999, 72:570-585.
54. Kitano Y., Radu A., Shaaban A., Flake A.W. Selection, enrichment, and culture expansion of murine mesenchymal progenitor cells by retroviral transduction of cycling adherent bone marrow cells. Exp Hematol 2000, 28:1460-1469.
55. Tropel P., Noel D., Platet N., Legrand P., Benabid A.L., Berger F. Isolation and characterisation of mesenchymal stem cells from adult mouse bone marrow. Exp Cell Res 2004, 295:395-406.
56. Meirelles Lda S., Nardi N.B. Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion, and characterization. Br J Haematol 2003, 123:702-711.
57. Peister A., Mellad J.A., Larson B.L., Hall B.M., Gibson L.F., Prockop D.J. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 2004, 103:1662-1668.
58. da Silva Meirelles L., Chagastelles P.C., Nardi N.B. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 2006, 119:2204-2213.
59. Jiang Y., Jahagirdar B.N., Reinhardt R.L., Schwartz R.E., Keene C.D., Ortiz-Gonzalez X.R., et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002, 418:41-49.
60. Hisha H., Nishino T., Kawamura M., Adachi S., Ikehara S. Successful bone marrow transplantation by bone grafts in chimeric-resistant combination. Exp Hematol 1995, 23:347-352.
61. Sun S., Guo Z., Xiao X., Liu B., Liu X., Tang P.H., et al. Isolation of mouse marrow mesenchymal progenitors by a novel and reliable method. Stem Cells 2003, 21:527-535.
62. Short B.J., Brouard N., Simmons P.J. Prospective isolation of mesenchymal stem cells from mouse compact bone. Methods Mol Biol 2009, 482:259-268.
63. Yamachika E., Tsujigiwa H., Matsubara M., Hirata Y., Kita K., Takabatake K., et al. Basic fibroblast growth factor supports expansion of mouse compact bone-derived mesenchymal stem cells (MSCs) and regeneration of bone from MSC in vivo. J Mol Histol 2012, 43:223-233.
64. Ball L.M., Bernardo M.E., Roelofs H., Lankester A., Cometa A., Egeler R.M., et al. Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood 2007, 110:2764-2767.
65. Le Blanc K., Frassoni F., Ball L., Locatelli F., Roelofs H., Lewis I., et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008, 371:1579-1586.
66. Caterson E.J., Nesti L.J., Danielson K.G., Tuan R.S. Human marrow-derived mesenchymal progenitor cells: isolation, culture expansion, and analysis of differentiation. Mol Biotechnol 2002, 20:245-256.
67. Sotiropoulou P.A., Perez S.A., Salagianni M., Baxevanis C.N., Papamichail M. Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells 2006, 24:462-471.
68. Shahdadfar A., Fronsdal K., Haug T., Reinholt F.P., Brinchmann J.E. In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. Stem Cells 2005, 23:1357-1366.
69. Spees J.L., Gregory C.A., Singh H., Tucker H.A., Peister A., Lynch P.J., et al. Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Mol Ther 2004, 9:747-756.
70. Doucet C., Ernou I., Zhang Y., Llense J.R., Begot L., Holy X., et al. Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J Cell Physiol 2005, 205:228-236.
71. Bernardo M.E., Avanzini M.A., Perotti C., Cometa A.M., Moretta A., Lenta E., et al. Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute. J Cell Physiol 2007, 211:121-130.
72. Jung S., Sen A., Rosenberg L., Behie L.A. Identification of growth and attachment factors for the serum-free isolation and expansion of human mesenchymal stromal cells. Cytotherapy 2010, 12:637-657.
73. Chase L.G., Lakshmipathy U., Solchaga L.A., Rao M.S., Vemuri M.C. A novel serum-free medium for the expansion of human mesenchymal stem cells. Stem Cell Res Ther 2010, 1:8.
74. Lennon D.P., Haynesworth S.E., Young R.G., Dennis J.E., Caplan A.I. A chemically defined medium supports in vitro proliferation and maintains the osteochondral potential of rat marrow-derived mesenchymal stem cells. Exp Cell Res 1995, 219:211-222.
75. Parker A.M., Shang H., Khurgel M., Katz A.J. Low serum and serum-free culture of multipotential human adipose stem cells. Cytotherapy 2007, 9:637-646.
76. Eslaminejad M.B., Taghiyar L. Study of the structure of canine mesenchymal stem cell osteogenic culture. Anat Histol Embryol 2010, 39:446-455.
77. Bellows C.G., Heersche J.N., Aubin J.E. Determination of the capacity for proliferation and differentiation of osteoprogenitor cells in the presence and absence of dexamethasone. Dev Biol 1990, 140:132-138.
78. Leboy P.S., Beresford J.N., Devlin C., Owen M.E. Dexamethasone induction of osteoblast mRNAs in rat marrow stromal cell cultures. J Cell Physiol 1991, 146:370-378.
79. Hong D., Chen H.X., Xue Y., Li D.M., Wan X.C., Ge R., et al. Osteoblastogenic effects of dexamethasone through upregulation of TAZ expression in rat mesenchymal stem cells. J Steroid Biochem Mol Biol 2009, 116:86-92.
80. Walsh S., Jordan G.R., Jefferiss C., Stewart K., Beresford J.N. High concentrations of dexamethasone suppress the proliferation but not the differentiation or further maturation of human osteoblast precursors in vitro: relevance to glucocorticoid-induced osteoporosis. Rheumatology (Oxford) 2001, 40:74-83.
81. Beck G.R., Zerler B., Moran E. Phosphate is a specific signal for induction of osteopontin gene expression. Proc Natl Acad Sci U S A 2000, 97:8352-8357.
82. Vater C., Kasten P., Stiehler M. Culture media for the differentiation of mesenchymal stromal cells. Acta Biomater 2011, 7:463-477.
83. Kim J., Kim I.S., Cho T.H., Lee K.B., Hwang S.J., Tae G., et al. Bone regeneration using hyaluronic acid-based hydrogel with bone morphogenic protein-2 and human mesenchymal stem cells. Biomaterials 2007, 28:1830-1837.
84. Akita S., Fukui M., Nakagawa H., Fujii T., Akino K. Cranial bone defect healing is accelerated by mesenchymal stem cells induced by coadministration of bone morphogenetic protein-2 and basic fibroblast growth factor. Wound Repair Regen 2004, 12:252-259.
85. Hallman M., Thor A. Bone substitutes and growth factors as an alternative/complement to autogenous bone for grafting in implant dentistry. Periodontology 2008, 47:172-192.
86. Yamada Y., Ueda M., Naiki T., Takahashi M., Hata K., Nagasaka T. Autogenous injectable bone for regeneration with mesenchymal stem cells and platelet-rich plasma: tissue-engineered bone regeneration. Tissue Eng 2004, 10:955-964.
87. Ito K., Yamada Y., Naiki T., Ueda M. Simultaneous implant placement and bone regeneration around dental implants using tissue-engineered bone with fibrin glue, mesenchymal stem cells and platelet-rich plasma. Clin Oral Implants Res 2006, 17:579-586.
88. Khojasteh A., Eslaminejad M.B., Nazarian H. Mesenchymal stem cells enhance bone regeneration in rat calvarial critical size defects more than platelete-rich plasma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008, 106:356-362. discussion 63.
89. Jafarian M., Eslaminejad M.B., Khojasteh A., Mashhadi Abbas F., Dehghan M.M., Hassanizadeh R., et al. Marrow-derived mesenchymal stem cells-directed bone regeneration in the dog mandible: a comparison between biphasic calcium phosphate and natural bone mineral. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008, 105:e14-e24.
90. Lee L.T., Kwan P.C., Chen Y.F., Wong Y.K. Comparison of the effectiveness of autologous fibrin glue and macroporous biphasic calcium phosphate as carriers in the osteogenesis process with or without mesenchymal stem cells. J Chin Med Assoc 2008, 71:66-73.
91. Bernardo M.E., Zaffaroni N., Novara F., Cometa A.M., Avanzini M.A., Moretta A., et al. Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res 2007, 67:9142-9149.
92. Stenderup K., Justesen J., Clausen C., Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 2003, 33:919-926.
93. Uccelli A., Moretta L., Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008, 8:726-736.
94. Tolar J., Nauta A.J., Osborn M.J., Panoskaltsis Mortari A., McElmurry R.T., Bell S., et al. Sarcoma derived from cultured mesenchymal stem cells. Stem Cells 2007, 25:371-379.
95. Miura M., Miura Y., Padilla-Nash H.M., Molinolo A.A., Fu B., Patel V., et al. Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells 2006, 24:1095-1103.
96. Zhou Y.F., Bosch-Marce M., Okuyama H., Krishnamachary B., Kimura H., Zhang L., et al. Spontaneous transformation of cultured mouse bone marrow-derived stromal cells. Cancer Res 2006, 66:10849-10854.
97. Rubio D., Garcia-Castro J., Martin M.C., de la Fuente R., Cigudosa J.C., Lloyd A.C., et al. Spontaneous human adult stem cell transformation. Cancer Res 2005, 65:3035-3039.
98. Bartmann C., Rohde E., Schallmoser K., Purstner P., Lanzer G., Linkesch W., et al. Two steps to functional mesenchymal stromal cells for clinical application. Transfusion 2007, 47:1426-1435.